Oncolytic Virus Immunotherapy Market - FDA Approval and Accelerated Pathways
Market Overview
The oncolytic virus market is experiencing regulatory emphasis where FDA approval pathways, accelerated development, and clinical trial optimization enable faster market access. The oncolytic virus market is projected to exceed USD 8.6 billion through 2030, with regulatory emphasis driven by breakthrough therapy designation, unmet medical needs, and accelerated approval...